Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Generating extra cash can help alleviate your debt burden. Explore various options to boost your income effectively.
20,698 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
In a volatile AI market, SoundHound AI posts a narrower loss for Q4 2025 and lifts 2025 revenue guidance, underscorin...
SpaceX is lining up a blockbuster IPO that could outpace the entire 2025 IPO slate. Analysts estimate a multi-billion...
Analysts boosted targets on UNFI and MTDR after solid quarterly results, signaling renewed investor optimism as pipel...
With $500 in hand, the big question is where to invest for the best balance of growth and risk. This article compares...
If you’re targeting 2030 for your retirement, timing your Social Security claim could be the biggest financial move y...
The AI stock story is shifting from last year’s heroes to new winners in 2026. This guide explains why the leadership...
A newly launched dividend strategy ETF seeks to offer both a solid income stream and rising dividends, challenging th...
If you’re wondering should apple stock before June 8, you’re not alone. This guide breaks down the catalysts, risks, ...
The market is hovering around record levels, but does that mean you should sit on the sidelines? Not necessarily. Thi...
As 2026 unfolds, Tesla and BYD are diverging on growth bets. This article weighs earnings, margins, and software stra...
Hedge funds are loading up on big software names as AI fuels new growth avenues, even as margins come under pressure....